tert-Butyl (1r,4r)-4-(dimethylamino)-cyclohexylcarbamate

Catalog No. :
ACJUGI384
CAS No. :
1286275-84-0
Molecular Formula :
C13H26N2O2
Molecular Weight :
242.36

IUPAC Name:tert-butyl ((1r,4r)-4-(dimethylamino)cyclohexyl)carbamate

tert-Butyl (1r,4r)-4-(dimethylamino)-cyclohexylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$150.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (1r,4r)-4-(dimethylamino)-cyclohexylcarbamate
IUPAC Nametert-butyl ((1r,4r)-4-(dimethylamino)cyclohexyl)carbamate
MDL No.MFCD26096763
Molecular FormulaC13H26N2O2
Molecular Weight242.36
SMILESCN(C)[C@H]1CC[C@H](NC(=O)OC(C)(C)C)CC1
InChI KeyBAKQGMLJAGYMQC-XYPYZODXSA-N
Synonymtert-butyl (1r,4r)-4-(diMethylaMino)cyclohexylcarbaMate;trans tert-butyl 4-(dimethylamino)cyclohexylcarbamate;tert-butyl trans-4-(dimethylamino)cyclohexylcarbamate;109686;tert-Butyl trans-N-[4-(dimethylamino)cyclohexyl]carbamate;Carbamic acid, N-[trans-4-(dimethylamino)cyclohexyl]-, 1,1-dimethylethyl ester;trans-N-Boc-4-(dimethylamino)cyclohexanamine;Rel-tert-butyl ((1r,4r)-4-(dimethylamino)cyclohexyl)carbamate
CAS No.1286275-84-0
PubChem CID66749557

Synthetic Route by SureRoute

1. ACJUGI384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOKQZ643 route compound structure diagram
    ACOKQZ643167298-52-4 In Stock
  4. Then
  5. ACJUGI384 route product structure diagram
    ACJUGI3841286275-84-0 In Stock
Inquiry

2. ACJUGI384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSWZT970 route compound structure diagram
    ACSWZT970294180-29-3 In Stock
  4. Then
  5. ACJUGI384 route product structure diagram
    ACJUGI3841286275-84-0 In Stock
Inquiry

Comments (0)